aducanumab (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Alzheimer Disease

Pending FDA approval to reduce progression of cognitive and functional impairments associated with Alzheimer disease

Next:

Pharmacology

Mechanism of Action

High affinity, fully human IgG1 monoclonal antibody that targets beta amyloid and binds to aggregated forms of beta-amyloid; preferentially binds to parenchymal over vascular amyloid; reduces plaque formation on neurons

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.